deferoxamine has been researched along with Papilledema in 1 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Papilledema: Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause OPTIC ATROPHY and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamed, LM | 1 |
Winward, KE | 1 |
Glaser, JS | 1 |
Schatz, NJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Incidence and Causes of Disc Edema in Patients With Chronic Kidney Disease[NCT00769834] | 0 participants (Actual) | Observational | 2010-01-31 | Withdrawn (stopped due to All investigators have moved to different oranizations) | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for deferoxamine and Papilledema
Article | Year |
---|---|
Optic neuropathy in uremia.
Topics: Adult; Deferoxamine; Female; Humans; Kidney Diseases; Male; Methylprednisolone; Middle Aged; Optic N | 1989 |